COVID-19 and healthcare

COVID-19 is the most significant global healthcare crisis in a century. While the speed and scale of the pandemic, and the response to it, has been remarkable, the impacts and changes caused will be profound and long-lasting.

Healthcare systems around the world have borne the full brunt of COVID-19. The pandemic has upended normal operations, backlogging an estimated 28 million procedures globally¹, exposed system and supply chain limitations, tested the physical and mental limits of health workers and caused rapid adoption of digital solutions. Despite these extraordinary challenges, there are also opportunities to drive positive change through these difficult times.

Until a vaccine is found health systems will need new ways of working to respond to these pressures as they move from crisis reaction through resilience, recovery and into the post-pandemic new reality. COVID-19 has also the potential to accelerate existing transformational changes that were already under way in more mature healthcare organizations, and move us towards the new reality for healthcare at a much faster pace than previously anticipated.

Since the start of the pandemic, at KPMG we have listened to clients, provided insights and supported COVID-19 engagements in some of the world’s largest healthcare markets. To further support leaders in this journey, over the coming weeks KPMG’s Global Healthcare Team will offer additional insights and practical advice that aims to ultimately create a complete vision on how to navigate the new reality.
 

KPMG’s Global Healthcare team has over 4,500 dedicated professionals with skills in strategy development, cost optimization, financial management, clinical performance improvement, health IT, digital innovation and transformation, market development, tax planning, mergers and acquisitions, commercialization and organizational development – making us one of the largest, best equipped and most experienced healthcare advisory teams.